Bilcare LtdHealthcare Research- Analytics and TechnologyINE986A01012
Valuation
Market Cap₹256.97 Cr
TTM PE-162.90x
Forward PE-73.74x
PEG4.11
Book Value—
P/B—
TTM EPS₹-0.67
Fwd EPS₹-1.48
TTM Revenue₹6.72 Cr
TTM PAT₹-2.33 Cr
TTM EBITDA₹-12.07 Cr
TTM EBIT₹-14.71 Cr
Last Qtr PAT₹-6.99 Cr
Last Qtr EBITDA₹-0.99 Cr
Last Qtr EBIT₹-1.59 Cr
Profitability
ROE—
ROCE0.00%
TTM NPM-34.67%
TTM EBITDA %-179.61%
Curr OPM46.91%
Last OPM-582.50%
Curr NPM—
Last NPM—
Curr EPS₹0.44
Last EPS₹-2.70
Balance sheet
Equity₹23.55 Cr
Reserve₹-319.52 Cr
Total Debt₹2,562.69 Cr
D/E—
Interest %13.19%
Curr Interest₹0.12 Cr
Price / range
Close₹109.14
vs 52W High-5.91%
vs 52W Low+118.28%
MA50—
MA200—
Returns
1D+4.99%
1W+17.05%
1M+7.22%
3M+94.27%
6M+91.61%
1Y+22.30%
2Y+71.39%
3Y+36.87%
5Y+55.91%
Diwali+39.21%
Sector peers — Healthcare Research- Analytics and Technology
| Company | Close | Mkt Cap | TTM P/E | ROE |
|---|
| SYNGENE | 369.05 | ₹14.90K Cr | 64.86 | 4.73% |
| INDGN | 600.10 | ₹14.46K Cr | 63.57 | 7.22% |
| SUVEN | 341.55 | ₹9.65K Cr | -141.72 | -9.50% |
| VIMTALABS | 603.10 | ₹2.69K Cr | 33.77 | 17.44% |
| BI | 109.14 | ₹256.97 Cr | -162.90 | — |
| TAKE | 15.96 | ₹236.10 Cr | 38.93 | 18.87% |
| JSTL | 81.25 | ₹161.84 Cr | 25.79 | — |
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits